Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Dow Jones

38,589.16

Get Started

Share Name	Share Symbol	Market	Type
OptiNose Inc	NASDAQ:OPTN	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.035	-2.94%	1.155	0.50	1.19	1.20	1.13	1.18	281,898	05:00:10

Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

17/05/2024 5:00pm

GlobeNewswire Inc.

OptiNose (NASDAQ:OPTN)
Historical Stock Chart

From Jun 2024 to Jun 2024

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor ContactJonathan Neelyjonathan.neely@optinose.com267.521.0531